4//SEC Filing
MILLIGAN JOHN F 4
Accession 0000950170-25-088484
CIK 0001650648other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:03 PM ET
Size
5.9 KB
Accession
0000950170-25-088484
Insider Transaction Report
Form 4
MILLIGAN JOHN F
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+33,750→ 33,750 totalExercise: $4.15Exp: 2035-06-16→ Common Stock (33,750 underlying)
Footnotes (2)
- [F1]Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
- [F2]The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2026 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2028. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001191589
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:03 PM ET
- Size
- 5.9 KB